Table 2.
Primary Outcome | Intravenous Therapy (1021) N (%) | Oral Therapy (948) N (%) | Propensity-score adjusted odds ratio (95% confidence interval) for those children treated with early transition to oral therapy |
---|---|---|---|
| |||
Treatment Failure within 6 months of diagnosis | 54 (5) | 38 (4) | 0.77 (0.49, 1.22) |
Chronic osteomyelitis | 13 (1.3) | 8 (0.8) | 0.84 (0.33, 2.13) |
Musculoskeletal surgery | 18 (1.8) | 15 (1.6) | 0.80 (0.38, 1.70) |
Complication of osteomyelitis** | 11 (1.1) | 6 (0.6) | 0.75 (0.27, 2.07) |
Acute osteomyelitis as sole readmission diagnosis | 12 (1.2) | 9 (0.9) | 0.72 (0.25, 2.08) |
| |||
Secondary Outcomes | |||
| |||
Any re-hospitalization within 6 months of diagnosis | 102 (10) | 56 (5.9) | 0.6 (0.38, 0.96) |
| |||
Catheter-associated complication | 35 (3) | 0 (0) | --- |
| |||
Adverse effect of antimicrobials^ | 15 (1.5) | 4 (0.4) | 0.39 (0.14, 1.1) |
Analysis used the complete cohort.
Includes synovitis, pyogenic arthritis, sacroilitis, disorders of bone and cartiliage NOS, and disc disorder
adverse drug reactions associated with antibiotics, C. difficile infection or agranulocytosis